Heartflow, Inc. Common Stock (HTFL) is a publicly traded the market company. As of May 21, 2026, HTFL trades at $27.38 with a market cap of $2.21B and a P/E ratio of -8.61. HTFL moved +3.08% today. Year to date, HTFL is -9.96%; over the trailing twelve months it is flat. Its 52-week range spans $20.13 to $41.22. Analyst consensus is strong buy with an average price target of $37.00. Rallies surfaces HTFL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Heartflow Data Shows 4x Risk from High Plaque Volume, NAVIGATE-PCI Registry Starts: Heartflow presented data from a 15,000-patient registry showing high plaque volume predicts a fourfold increase in major adverse cardiovascular events regardless of risk factors or stenosis severity. It enrolled the first patient in its 5,000-patient NAVIGATE-PCI Registry to test AI-guided CT planning’s effect on clinical strategy and physician confidence.
| Metric | Value |
|---|---|
| Price | $27.38 |
| Market Cap | $2.21B |
| P/E Ratio | -8.61 |
| EPS | $-3.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.22 |
| 52-Week Low | $20.13 |
| Volume | 558 |
| Avg Volume | 0 |
| Revenue (TTM) | $176.03M |
| Net Income | $-116.79M |
| Gross Margin | 76.80% |
7 analysts cover HTFL: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.00.